India Sued By Becton Dickinson Of U.S. Over Medical Device Bid Process
This article was originally published in PharmAsia News
Executive SummaryIndia's Health Ministry has been sued by the India unit of Becton Dickinson, a maker of medical devices in the United States, for violating India's own rules on bidding. Also named in the BD India suit was Hindustan Syringes & Medical Devices, Iscon Surgicals, both of India, and Wuxi Yushou Medical Appliances of China. The suit alleges the ministry canceled a tender while it was still open and floated a new one. BD India contends its bid was the lowest, yet the ministry intended to buy products from a competitor. The government said it had valid reasons for ending the first tender. (Click here for more
You may also be interested in...
Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.
Analyzing Quality Data Is Essential. Here’s What One Expert Says Your Firm Should Do To Stay In FDA’s Good Graces
Device makers should make sure they have adequate resources to analyze quality data they take in so they can prevent the recurrence of nonconforming products, processes and procedures. That’s just one nugget of advice from former FDA investigations branch director Ricki Chase, who explains why collecting and properly handling such data is critical to complying with agency expectations in this Medtech Insight Q&A interview.